Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
H&D Wireless Sweden Holding B | HDWB | Sep 19, 2024 | 0.00 | +2.22 |
H&M B | HMB | Sep 19, 2024 | 178.35 | +1.71 |
HAKI Safety A | HAKIA | Sep 19, 2024 | 28.00 | 0.00 |
HAKI Safety B | HAKIB | Sep 19, 2024 | 28.00 | -1.06 |
Hamlet BioPharma AB (publ) | HAMLETB | Sep 19, 2024 | 3.44 | +0.88 |
Hansa Biopharma | HNSA | Sep 19, 2024 | 42.64 | +0.33 |
Hanza AB | HANZA | Sep 19, 2024 | 56.35 | -5.29 |
Harm Reduction Group | NOHARM | Sep 19, 2024 | 0.07 | -0.30 |
Havsfrun Investment | HAVS | Sep 19, 2024 | 11.95 | +8.64 |
Havsfrun Investment B | HAVB | Sep 19, 2024 | 11.95 | +8.64 |
Haypp Group | HAYPP | Sep 19, 2024 | 86.40 | +4.10 |
Headsent | VIMAB | Sep 19, 2024 | 8.65 | +4.22 |
Heba B | HEBAB | Sep 19, 2024 | 34.85 | +2.20 |
Hedera Group | HEGR | Sep 19, 2024 | 3.84 | -1.54 |
Heimstaden Pref | HEIMPREF | Sep 19, 2024 | 15.82 | +2.33 |
Heliospectra | HELIO | Sep 19, 2024 | 0.65 | 0.00 |
Hemnet Group | HEM | Sep 19, 2024 | 368.00 | +1.55 |
Hemply Balance | HMPLY | Sep 19, 2024 | 0.03 | +6.90 |
Hernö Gin B | HERNOB | Sep 19, 2024 | 4.95 | 0.00 |
Hexagon B | HEXAB | Sep 19, 2024 | 103.30 | +3.63 |
Hexagon Purus | HPURO | Sep 19, 2024 | 10.36 | +6.04 |
Hexatronic Group | HTRO | Sep 19, 2024 | 52.64 | +1.11 |
Hexicon | HEXI | Sep 19, 2024 | 0.28 | +6.56 |
Hexpol B | HPOLB | Sep 19, 2024 | 111.20 | +0.36 |
Hifab B | HIFAB | Sep 19, 2024 | 3.12 | 0.00 |
High Coast Distillery B | HIGHCOB | Sep 19, 2024 | 39.20 | -2.97 |
Hilbert | HILBB | Sep 19, 2024 | 5.28 | -1.49 |
HMS Networks | HMS | Sep 19, 2024 | 394.40 | +1.44 |
Hoegh Autoliners ASA | HAUTOO | Sep 19, 2024 | 142.00 | +1.87 |
Hoi Publishing AB | HOIB | Sep 19, 2024 | 0.31 | +3.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.